Med Prvdrs Mutl Ins Co A RRG
Major Rating Factors:
Weak overall results on stability tests (2.1 on a scale of 0 to 10) including weak results on operational trends, weak risk diversification and negative cash flow from operations for 2024. The largest net exposure for one risk is acceptable at 2.7% of capital. Good overall profitability index (6.1) despite operating losses during 2021 and the first three months of 2025. Return on equity has been good over the last five years, averaging 10.9%. Strong long-term capitalization index (10.0) based on excellent current risk adjusted capital (severe and moderate loss scenarios), despite some fluctuation in capital levels.
Other Rating Factors:
Ample reserve history (9.9) that helps to protect the company against sharp claims increases. Superior liquidity (10.0) with ample operational cash flow and liquid investments.
Stability Factors:
D - Limited diversification of general business, policy, and/or investment risk.
F - Negative cash flow.
R - Concerns about the financial strength of its reinsurers.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Med mal (100.0%)
Licensed in:
DC
Principal Investments:
Investment grade bonds (76.4%), cash (21.4%), preferred stock (2.0%), other (0.2%)
Ratios
Premium to Surplus
Reserve to Surplus
1-Year Reserve Development
2-Year Reserve Development
Expense Ratio
Combined Ratio
Cash From Underwriting
Net Premium Growth
Investments in Affiliates
--
Corporate Info
Group Affiliation
None
Investment Rating
--
Company Address
1050 30th Street, NW
Washington, DC 20007
Washington, DC 20007
Phone Number
(802) 479-7802
NAIC Number
11813
Website
Largest Affiliates
No affiliate information available.